CASE AND RESEARCH LETTER
Skin Toxicity Due to Telaprevir: A New Drug We Should Be Familiar With
Toxicidad cutánea por telaprevir: un nuevo fármaco que es necesario conocer
M.T. López-Villaescusa
, L.J. Pérez-García, M. Rodríguez-Vázquez, M.L. Martínez-Martínez
Autor para correspondencia
Servicio de Dermatología, Complejo Hospitalario Universitario de Albacete, Albacete, Spain
Leído
7512
Vecesse ha leído el artículo
2199
Total PDF
5313
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 63 | 11 | 74 |
| 2025 5 | 158 | 39 | 197 |
| 2025 4 | 157 | 20 | 177 |
| 2025 3 | 164 | 16 | 180 |
| 2025 2 | 176 | 23 | 199 |
| 2025 1 | 92 | 31 | 123 |
| 2024 12 | 80 | 34 | 114 |
| 2024 11 | 106 | 75 | 181 |
| 2024 10 | 74 | 46 | 120 |
| 2024 9 | 86 | 18 | 104 |
| 2024 8 | 116 | 74 | 190 |
| 2024 7 | 78 | 31 | 109 |
| 2024 6 | 104 | 44 | 148 |
| 2024 5 | 70 | 33 | 103 |
| 2024 4 | 109 | 22 | 131 |
| 2024 3 | 146 | 29 | 175 |
| 2024 2 | 93 | 23 | 116 |
| 2024 1 | 88 | 25 | 113 |
| 2023 12 | 49 | 17 | 66 |
| 2023 11 | 93 | 22 | 115 |
| 2023 10 | 111 | 20 | 131 |
| 2023 9 | 67 | 34 | 101 |
| 2023 8 | 51 | 18 | 69 |
| 2023 7 | 84 | 31 | 115 |
| 2023 6 | 50 | 19 | 69 |
| 2023 5 | 67 | 25 | 92 |
| 2023 4 | 49 | 20 | 69 |
| 2023 3 | 83 | 17 | 100 |
| 2023 2 | 77 | 28 | 105 |
| 2022 1 | 53 | 23 | 76 |
| 2022 12 | 62 | 24 | 86 |
| 2022 11 | 53 | 33 | 86 |
| 2022 10 | 37 | 15 | 52 |
| 2022 9 | 32 | 46 | 78 |
| 2022 8 | 43 | 42 | 85 |
| 2022 7 | 38 | 30 | 68 |
| 2022 6 | 36 | 25 | 61 |
| 2022 5 | 35 | 51 | 86 |
| 2022 4 | 38 | 25 | 63 |
| 2022 3 | 54 | 55 | 109 |
| 2022 2 | 57 | 26 | 83 |
| 2021 1 | 45 | 46 | 91 |
| 2021 12 | 35 | 33 | 68 |
| 2021 11 | 50 | 41 | 91 |
| 2021 10 | 40 | 52 | 92 |
| 2021 9 | 28 | 31 | 59 |
| 2021 8 | 25 | 40 | 65 |
| 2021 7 | 22 | 27 | 49 |
| 2021 6 | 32 | 36 | 68 |
| 2021 5 | 41 | 28 | 69 |
| 2021 4 | 70 | 51 | 121 |
| 2021 3 | 78 | 12 | 90 |
| 2021 2 | 37 | 18 | 55 |
| 2020 1 | 31 | 14 | 45 |
| 2020 12 | 31 | 10 | 41 |
| 2020 11 | 20 | 5 | 25 |
| 2020 10 | 30 | 7 | 37 |
| 2020 9 | 19 | 15 | 34 |
| 2020 8 | 26 | 10 | 36 |
| 2020 7 | 27 | 6 | 33 |
| 2020 6 | 22 | 16 | 38 |
| 2020 5 | 23 | 9 | 32 |
| 2020 4 | 33 | 7 | 40 |
| 2020 3 | 24 | 9 | 33 |
| 2020 2 | 7 | 0 | 7 |
| 2020 1 | 0 | 3 | 3 |
| 2019 12 | 4 | 4 | 8 |
| 2019 11 | 0 | 1 | 1 |
| 2019 9 | 4 | 2 | 6 |
| 2019 7 | 0 | 1 | 1 |
| 2019 6 | 2 | 0 | 2 |
| 2019 5 | 1 | 8 | 9 |
| 2019 4 | 0 | 14 | 14 |
| 2019 3 | 2 | 8 | 10 |
| 2019 1 | 2 | 5 | 7 |
| 2018 12 | 1 | 0 | 1 |
| 2018 11 | 1 | 0 | 1 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 4 | 0 | 4 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 57 | 5 | 62 |
| 2018 1 | 47 | 2 | 49 |
| 2017 12 | 65 | 6 | 71 |
| 2017 11 | 50 | 5 | 55 |
| 2017 10 | 27 | 2 | 29 |
| 2017 9 | 19 | 4 | 23 |
| 2017 8 | 24 | 6 | 30 |
| 2017 7 | 24 | 7 | 31 |
| 2017 6 | 37 | 9 | 46 |
| 2017 5 | 32 | 4 | 36 |
| 2017 4 | 30 | 11 | 41 |
| 2017 3 | 25 | 7 | 32 |
| 2017 2 | 21 | 10 | 31 |
| 2016 1 | 26 | 5 | 31 |
| 2016 12 | 37 | 11 | 48 |
| 2016 11 | 48 | 8 | 56 |
| 2016 10 | 54 | 9 | 63 |
| 2016 9 | 69 | 6 | 75 |
| 2016 8 | 35 | 3 | 38 |
| 2016 7 | 41 | 3 | 44 |
| 2016 6 | 10 | 0 | 10 |
| 2016 5 | 9 | 5 | 14 |
| 2016 4 | 4 | 0 | 4 |
| 2016 3 | 5 | 0 | 5 |
| 2016 2 | 6 | 3 | 9 |
| 2015 1 | 10 | 1 | 11 |
| 2015 12 | 3 | 0 | 3 |
| 2015 11 | 5 | 0 | 5 |
| 2015 10 | 2 | 3 | 5 |
| 2015 9 | 1 | 2 | 3 |
| 2015 8 | 11 | 2 | 13 |
| 2015 7 | 29 | 8 | 37 |
| 2015 6 | 38 | 6 | 44 |
| 2015 5 | 52 | 2 | 54 |
| 2015 4 | 27 | 4 | 31 |
| 2015 3 | 21 | 5 | 26 |
| 2015 2 | 16 | 1 | 17 |
| 2015 1 | 25 | 1 | 26 |
| 2014 12 | 36 | 5 | 41 |
| 2014 11 | 16 | 5 | 21 |
| 2014 10 | 17 | 6 | 23 |
| 2014 9 | 16 | 4 | 20 |
| 2014 8 | 10 | 3 | 13 |
| 2014 7 | 10 | 5 | 15 |
| 2014 6 | 20 | 5 | 25 |
| 2014 5 | 20 | 156 | 176 |
| 2014 4 | 26 | 35 | 61 |
Mostrar todo
